ASML raised full-year 2026 guidance again after reporting third-quarter net sales of €11.7 billion and net income of €5.0 billion on October 14, 2026. Even so, ASML shares are trading below the sho...
ASML’s latest reported catalyst is fundamental, not technical: on October 14, 2026, the company said third-quarter total net sales were €11.7 billion, gross margin was 57.5%, and net income was €5.0 billion. It also raised full-year 2026 sales guidance to €44 billion-€45 billion and reiterated gross margin around 56%, while Q4 sales were guided to €14.2 billion-€15.2 billion and margin around 57%. That matters because the market is not dealing with a vague AI story; ASML is now putting higher revenue and margin assumptions behind the demand backdrop. citeturn0search0
A fresh report on November 16, 2026 added that several firms moved targets around the name: Citigroup lifted its target to $2,300 from $2,200, HSBC raised to $2,261 from $2,177, Jefferies cut to $1,590 from $1,650, and JPMorgan trimmed to $2,350 from $2,400. The direction of those revisions is not uniform, but the range shows the name remains heavily debated even after the stronger outlook. citeturn0search1
ASML shares were at $1,463.87 in the latest data, down 0.85% on the day and still below the 7-day SMA at $1,494.75, the 20-day SMA at $1,512.00, and the 50-day SMA at $1,639.30. That is a bearish moving-average stack, and it tells you the stock has not yet reclaimed a clean trend structure despite the stronger company outlook. citeturn0search2
Source link







